Sanovel was established in 1983 by pharmacist Erol Toksoz. The company started its production life with 5 employees in 1983, while today it operates on the Turkish Pharmaceutical Sector within modern facilities with an indoor space of 59,000 sqm, located on an area of 125,000 sqm in total.
Investing in R&D and new technologies in production with a dedicated team of specialists, Sanovel moves forward towards being a global player in the pharmaceutical industry.
The company lists some of its main characteristics as follows: EU approved GMP production site; Main Production Unit for solid, semi-solid, liquid and sterile liquid productions; GMP approved, dedicated Biotech Production Unit; Dedicated Cephalosporin Production Unit; DPI production site; Dedicated R&D Centre; Patented medical device for DPI (first in the Turkish Market); 365 patent applications and 151 granted patents in TR, EU and USA; Growing development pipeline; Global presence with over 700 marketing authorizations.
LATEST issue 3/2020
The Hannover Messe Digital Days revolve around the content of the show. The conference programme focuses on topics such as Industry 4.0, artificial intelligence, smart energy and Logistics 4.0. Read more here...